Jianmin Pharmaceutical Group Co (SHSE:600976) Days Sales Outstanding

: 75.02 (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

Jianmin Pharmaceutical Group Co's average Accounts Receivable for the three months ended in Dec. 2023 was ¥901 Mil. Jianmin Pharmaceutical Group Co's Revenue for the three months ended in Dec. 2023 was ¥1,096 Mil. Hence, Jianmin Pharmaceutical Group Co's Days Sales Outstanding for the three months ended in Dec. 2023 was 75.02.

The historical rank and industry rank for Jianmin Pharmaceutical Group Co's Days Sales Outstanding or its related term are showing as below:

SHSE:600976' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.86 Med: 57.93 Max: 73.6
Current: 73.6

During the past 13 years, Jianmin Pharmaceutical Group Co's highest Days Sales Outstanding was 73.60. The lowest was 44.86. And the median was 57.93.

SHSE:600976's Days Sales Outstanding is ranked worse than
51.45% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 72.07 vs SHSE:600976: 73.60

Jianmin Pharmaceutical Group Co's Days Sales Outstanding increased from Dec. 2022 (74.47) to Dec. 2023 (75.02).

Jianmin Pharmaceutical Group Co Days Sales Outstanding Historical Data

The historical data trend for Jianmin Pharmaceutical Group Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jianmin Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

52.37

49.29

44.86

56.01

64.84

Jianmin Pharmaceutical Group Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding																74.47	68.90	71.85	88.69	75.02

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Jianmin Pharmaceutical Group Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jianmin Pharmaceutical Group Co Days Sales Outstanding Distribution

For the Drug Manufacturers industry and Healthcare sector, Jianmin Pharmaceutical Group Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Jianmin Pharmaceutical Group Co's Days Sales Outstanding falls into.

Jianmin Pharmaceutical Group Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Jianmin Pharmaceutical Group Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (638.342	+	858.462)	/	2 )	/	4213.155	*	365
=	748.402					/	4213.155	*	365
=	64.84

Jianmin Pharmaceutical Group Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (942.787	+	858.462)	/	2 )	/	1095.535	*	365 / 4
=	900.6245					/	1095.535	*	365 / 4
=	75.02

Jianmin Pharmaceutical Group Co (SHSE:600976) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Jianmin Pharmaceutical Group Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Jianmin Pharmaceutical Group Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Jianmin Pharmaceutical Group Co (SHSE:600976) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jianmin Pharmaceutical Group Co Ltd (SHSE:600976) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

No. 484 Parrot Avenue, Hanyang District, Wuhan, CHN, 430052

Website

http://www.whjm.com

Jianmin Pharmaceutical Group Co Ltd is engaged in the manufacture and distribution of pharmaceutical products. It adheres to the core position of pediatric medicine, gynecological medicine, and special Chinese medicine, it offers products under Jianmin and Longmu brands.

Jianmin Pharmaceutical Group Co (SHSE:600976) Headlines

No Headlines